Eprax

N/A

Report date: 2026/03/30 20:02:02

Base Information

Drug NameEprax
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionEPO replacements
TargetsErythropoietin
Therapy Area/IndicationsOptic AtrophyOptic Nerve Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlexandria University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlexandria University
Active IndicationsOptic Atrophy
Inactive IndicationsOptic Nerve Diseases

Other Information

ATC CodeN/A
Related LinksN/A